Search Results - Karen E Pollok

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Melanoma LAMP-2C Modulates Tumor Growth and Autophagy

    Melanoma LAMP-2C Modulates Tumor Growth and Autophagy by Liliana Pérez, Anthony L. Sinn, George E. Sandusky, Karen E. Pollok, Karen E. Pollok, Karen E. Pollok, Janice S. Blum

    Published 2018-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    3552 Advancing Glioblastoma (GBM) drug regimen development to support combination therapy through integrated PKPD modeling and simulation-based predictions

    3552 Advancing Glioblastoma (GBM) drug regimen development to support combination therapy through integrated PKPD modeling and simulation-based predictions by Saugat Adhikari, Harlan E. Shannon, Karen E. Pollok, Robert E. Stratford

    Published 2019-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches

    The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches by Pankita H. Pandya, Mary E. Murray, Karen E. Pollok, Jamie L. Renbarger

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    134 Tumor-responsive, multi-functional genetically-engineered natural killer cells for immunotherapy of glioblastoma

    134 Tumor-responsive, multi-functional genetically-engineered natural killer cells for immunotherapy of glioblastoma by Jiao Wang, Yeonhee Yun, Karen E Pollok, Anthony L Sinn, Randy R Brutkiewicz, Michael C Veronesi

    Published 2020-11-01
    Article
    Save to List
    Saved in:
  5. 5
    15 A novel CD28 humanized mouse model for efficacy assessment of CD28-targeting therapies

    15 A novel CD28 humanized mouse model for efficacy assessment of CD28-targeting therapies by Jiao Wang, Yeonhee Yun, Karen E Pollok, Anthony L Sinn, Randy R Brutkiewicz, Michael C Veronesi

    Published 2020-11-01
    Article
    Save to List
    Saved in:
  6. 6
    Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

    Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer by Jeffrey P. Solzak, Rutuja V. Atale, Bradley A. Hancock, Anthony L. Sinn, Karen E. Pollok, David R. Jones, Milan Radovich

    Published 2017-04-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition.

    Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition. by R Marisol Herrera-Perez, Sherry L Voytik-Harbin, Jann N Sarkaria, Karen E Pollok, Melissa L Fishel, Jenna L Rickus

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    The Role of MDM2 in Promoting Genome Stability versus Instability

    The Role of MDM2 in Promoting Genome Stability versus Instability by M. Reza Saadatzadeh, Adily N. Elmi, Pankita H. Pandya, Khadijeh Bijangi-Vishehsaraei, Jixin Ding, Christopher W. Stamatkin, Aaron A. Cohen-Gadol, Karen E. Pollok

    Published 2017-10-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer

    A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer by Qiaomu Tian, Peng Zhang, Yihan Wang, Youhui Si, Dengping Yin, Christopher R Weber, Melissa L Fishel, Karen E Pollok, Bo Qiu, Fei Xiao, Anita S Chong

    Published 2023-10-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14

    Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14 by Kamakshi Sishtla, Natalie Pitt, Mehdi Shadmand, Michael N. O’Hare, Rania S. Sulaiman, Anthony L. Sinn, Keith Condon, Karen E. Pollok, George E. Sandusky, Timothy W. Corson

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining

    Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining by Xiaohui Zhan, Yusong Liu, Asha Jacob Jannu, Shaoyang Huang, Bo Ye, Wei Wei, Pankita H. Pandya, Xiufen Ye, Karen E. Pollok, Jamie L. Renbarger, Kun Huang, Jie Zhang

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Characterization and initial demonstration of in vivo efficacy of a novel heat-activated metalloenediyne anti-cancer agent

    Characterization and initial demonstration of in vivo efficacy of a novel heat-activated metalloenediyne anti-cancer agent by Joy Garrett, Erin Metzger, Mark W. Dewhirst, Karen E. Pollok, John J. Turchi, Isabelle C. Le Poole, Kira Couch, Logan Lew, Anthony Sinn, Jeffrey M. Zaleski, Joseph R. Dynlacht

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma

    TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma by Kyle B. Lupo, Sandra Torregrosa-Allen, Bennett D. Elzey, Sagar Utturkar, Nadia A. Lanman, Aaron A. Cohen-Gadol, Veronika Slivova, MacKenzie McIntosh, Karen E. Pollok, Sandro Matosevic

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    In Vivo Targeting Replication Protein A for Cancer Therapy

    In Vivo Targeting Replication Protein A for Cancer Therapy by Pamela S. VanderVere-Carozza, Navnath S. Gavande, Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci, Joshua Heyza, Steve M. Patrick, Andi Masters, John J. Turchi, John J. Turchi, Katherine S. Pawelczak

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes

    Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes by Kexin Li, Xun Sun, Hudie Li, Hailan Ma, Meng Zhou, Kazumasa Minami, Keisuke Tamari, Kazuhiko Ogawa, Pankita H. Pandya, M. Reza Saadatzadeh, Melissa A. Kacena, Karen E. Pollok, Bai-Yan Li, Hiroki Yokota

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins

    Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins by Kexin Li, Qingji Huo, Nathan H Dimmitt, Guofan Qu, Junjie Bao, Pankita H Pandya, M Reza Saadatzadeh, Khadijeh Bijangi-Vishehsaraei, Melissa A Kacena, Karen E Pollok, Chien-Chi Lin, Bai-Yan Li, Hiroki Yokota

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma

    Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma by Lijun Cheng, Pankita H. Pandya, Enze Liu, Pooja Chandra, Limei Wang, Mary E. Murray, Jacquelyn Carter, Michael Ferguson, Mohammad Reza Saadatzadeh, Khadijeh Bijangi-Visheshsaraei, Mark Marshall, Lang Li, Karen E. Pollok, Jamie L. Renbarger

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development.

    Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development. by Timothy W Corson, Brian C Samuels, Andrea A Wenzel, Anna J Geary, Amanda A Riley, Brian P McCarthy, Helmut Hanenberg, Barbara J Bailey, Pamela I Rogers, Karen E Pollok, Gangaraju Rajashekhar, Paul R Territo

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic Rag2-null rat model of glioblastoma

    Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic Rag2-null rat model of glioblastoma by Luke R. Jackson, Megan R. Masi, Bryce M. Selman, George E. Sandusky, Hamideh Zarrinmayeh, Sudip K. Das, Surendra Maharjan, Nian Wang, Qi-Huang Zheng, Karen E. Pollok, Scott E. Snyder, Phillip Zhe Sun, Gary D. Hutchins, Elizabeth R. Butch, Michael C. Veronesi

    Published 2022-11-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion

    Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion by Nur P. Damayanti, M. Reza Saadatzadeh, Erika Dobrota, Josue D. Ordaz, Barbara J. Bailey, Pankita H. Pandya, Khadijeh Bijangi-Vishehsaraei, Harlan E. Shannon, Anthony Alfonso, Kathy Coy, Melissa Trowbridge, Anthony L. Sinn, Zhong-Yin Zhang, Rosa I. Gallagher, Julia Wulfkuhle, Emanuel Petricoin, Angela M. Richardson, Mark S. Marshall, Alex Lion, Michael J. Ferguson, Karl E. Balsara, Karen E. Pollok

    Published 2023-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: